Literature DB >> 27015937

Adherence in outpatients taking warfarin and its effect on anticoagulation control in Jordan.

Mera A Ababneh1, Sayer I Al-Azzam2, Karem H Alzoubi2, Abeer M Rababa'h2.   

Abstract

Background Medication adherence is an important element for the success of any therapeutic plan. The picture is more complicated with warfarin, due to its small therapeutic window and patients' needs to have effective anticoagulation control. Objective To measure warfarin-adherence, warfarin-knowledge and to assess the relationship between adherence and anticoagulation control. Setting Adult outpatients (≥18 years) taking warfarin at two medical sites in north of Jordan were invited to participate. Method This was a cross sectional study in which survey questionnaire that included demographic, clinical, warfarin related questions and Morisky Medication Adherence Scale (MMAS-8) was administered to patients in Arabic language. International normalization ratio (INR) readings were retrieved from patients' medical records. Main outcome measure MMAS-8 adherence scores and time within therapeutic range were calculated. Results More than half of study participants (54 %) were adherent (MMAS-8 = 8). The MMAS-8 adherence scores were significantly associated with warfarin-knowledge scores (Spearman's ρ = 0.291, p = 0.000). Adherent patients were more likely to have good anticoagulation control compared to non-adherent patients (MMAS-8 ≤ 7). Conclusion Adherence to warfarin therapy can have a substantial effect on anticoagulation control. Thus, healthcare practitioners should consider strategies to improve patient adherence to warfarin.

Entities:  

Keywords:  Adherence; Anticoagulation control; Jordan; Knowledge; MMAS-8; Warfarin

Mesh:

Substances:

Year:  2016        PMID: 27015937     DOI: 10.1007/s11096-016-0282-9

Source DB:  PubMed          Journal:  Int J Clin Pharm


  23 in total

1.  Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control.

Authors:  Alfredo Dias Oliveira-Filho; José Augusto Barreto-Filho; Sabrina Joany Felizardo Neves; Divaldo Pereira de Lyra Junior
Journal:  Arq Bras Cardiol       Date:  2012-06-07       Impact factor: 2.000

2.  Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic.

Authors:  Ian A Orensky; David A Holdford
Journal:  Pharmacotherapy       Date:  2005-12       Impact factor: 4.705

3.  Factors affecting medication adherence and anticoagulation control in Korean patients taking warfarin.

Authors:  Jae Hee Kim; Gwang Suk Kim; Eun Jung Kim; Sungha Park; Namsik Chung; Sang Hui Chu
Journal:  J Cardiovasc Nurs       Date:  2011 Nov-Dec       Impact factor: 2.083

4.  Improving the measurement of self-reported medication nonadherence: response to authors.

Authors:  Donald E Morisky; M Robin DiMatteo
Journal:  J Clin Epidemiol       Date:  2010-12-08       Impact factor: 6.437

5.  An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.

Authors:  John F Carlquist; Benjamin D Horne; Chrissa Mower; James Park; John Huntinghouse; Jason T McKinney; Joseph B Muhlestein; Jeffrey L Anderson
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

6.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension.

Authors:  Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner
Journal:  Am J Manag Care       Date:  2009-01       Impact factor: 2.229

7.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

8.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

9.  Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin.

Authors:  Ye Wang; Ming Chai Kong; Yu Ko
Journal:  Thromb Haemost       Date:  2012-07-26       Impact factor: 5.249

10.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota.

Authors:  M J Gitter; T M Jaeger; T M Petterson; B J Gersh; M D Silverstein
Journal:  Mayo Clin Proc       Date:  1995-08       Impact factor: 7.616

View more
  5 in total

1.  Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China.

Authors:  Shujuan Zhao; Hongwei Zhao; Xianpei Wang; Chuanyu Gao; Yuhua Qin; Haixia Cai; Boya Chen; Jingjing Cao
Journal:  Patient Prefer Adherence       Date:  2017-02-09       Impact factor: 2.711

2.  Anticoagulation with Warfarin: Roles of Adherence, Social Support and Illness Perception.

Authors:  Saiful Nizam M V Mohamed Koya
Journal:  Innov Pharm       Date:  2019-10-31

3.  Warfarin Adherence Among Patients with Atrial Fibrillation in Rural Area of Dongyang, China: A Questionnaire-Based Study.

Authors:  Huadong Chen; Xing'e Xu; Jiren Peng; Xuan Ge; Jing'an Zhang; Qianqian Dong; Xiunan Jiang; Piaopiao Li
Journal:  Patient Prefer Adherence       Date:  2022-08-25       Impact factor: 2.314

4.  Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range.

Authors:  Leiliane Marcatto; Bruno Boer; Luciana Sacilotto; Natália Olivetti; Francisco Carlos Costa Darrieux; Maurício Ibrahim Scanavacca; Alexandre Costa Pereira; Paulo Caleb Junior Lima Santos
Journal:  J Thromb Thrombolysis       Date:  2020-09-24       Impact factor: 2.300

5.  Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: A hospital-based study in Saudi Arabia.

Authors:  Balkhi Balkhi; Mabrouk Al-Rasheedi; Abuabker Ibrahim Elbur; Ahmad Alghamadi
Journal:  Saudi Pharm J       Date:  2017-11-28       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.